维普期刊资源整合服务平台（V6.5）

194篇 您的检索式：作者名="Heneka"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists显示文摘	Grommes C Landreth GE Heneka MT	2004	Lancet Oncol2004，5，：	2
2	Innate immune activation in neum- degenerative disease 显示文摘	Heneka MT Kummer MP Latz E	2014	Nat Rev Immunol2014，14，7：	1
3	Neuroinflammatory processes in Alzheimer's disease显示文摘	Heneka MT O'Banion MK Terwel D	2010	J Neural Transm2010，117，8：	1
4	Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abetal-42 levels in APPV717I transgenic mice 显示文摘	Heneka MT Sastre M Dumitrescu-Ozimek L	2005	Brain2005，128，6：	1
5	Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation 显示文摘	Dehmer T Heneka MT Sastre M	2004	Neurochemistry2004，88，4：	1
6	Expression and function of inducible nitric oxide synthase in neurons 显示文摘	Heneka MT Feinstein DL	2001	J Neuroimmunol2001，114，12：	1
7	Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation显示文摘	Dehmer T Heneka MT Sastre M	2004	J Neurochem2004，88，2：	1
8	The role of pemxisome proliferator-activa-ted receptor-gamma in Alzheimer's disease:therapeutic impli-rations显示文摘	Heneka M	2008	CNS Drugs2008，22，1：	1
9	The role of peroxisome proliferator-activated receptor-γ (PPARγ) in Alzheimer's disease:therapeutic implications显示文摘	Jiang Q Heneka M Landreth GE	2008	CNS Drugs2008，22，1：	1
10	Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta 1-42 levels in APPV717I transgenic mice显示文摘	Heneka MT Sastre M Dumitrescu-Ozimek L Hanke A Dewachter I Kuiperi C	2005	Brain2005，128，6：	1
11	NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PSI mice显示文摘	Heneka M T Kummer M P Stutz A	2013	Nature2013，493，7434：	1
12	Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation显示文摘	DEHMER T HENEKA M T SASTRE M	2004	J Neurochem2004，88，2：	1
13	Expression and function of inducible nitric oxide synthase in neurons显示文摘	Heneka MT Feinstein DL	2001	J Neuroimmunol2001，114，12：	1
14	Noradrenergic depletion increases inflammatory responses in brain: effects on I kappa B and HSP70 expression显示文摘	Heneka M T Gavrilyuk V Landveth G E	2003	J Neurochem2003，85，：	1
15	Inflammatory processes in Alzheimer's disease 显示文摘	Heneka MT O'Banion MK	2007	J Neuroimmunol2007，184，：	1
16	The heat shock response inhibits NF-kB activation, nitric oxide synthase type 2 expression, and macrophage/microglial activation in brain显示文摘	Heneka T Sharp A Klockgether T	2000	J Cereb Blood Flow Metab2000，20，：	1
17	EFNS ‐ ENS / EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer’s disease显示文摘	R. Schmidt E. Hofer F. H. Bouwman K. Buerger C. Cordonnier T. Fladby D. Galimberti J. Georges M. T. Heneka J. Hort J. Laczó J. L Molinuevo J. T. O’Brien D. Religa P. Scheltens J. M. Schott S. Sorbi	2015	Eur J Neurol2015，，：	1
18	Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo显示文摘	Heneka MT Klockgether T Feinstein DL	2000	J Neurosci2000，20，18：	1
19	Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation显示文摘	Dehmer T Heneka MT Sastre M	2004	J Neurochem2004，88，2：	1
20	Contribution of inflammatory processes to Alzheimer's disease:molecular mechanisms显示文摘	Sastre M Klockgether T Heneka M T	2006	Int J Dev Neurosci2006，24，23：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示